In-situ Coronary Thrombosis in Antiphospholipid Syndrome: A Case Report

Antiphospholipid antibody syndrome (APS) is a systemic autoimmune disorder characterized by arterial and venous thrombosis, often accompanied by elevated titers of anti-phospholipid antibodies. Cardiac involvement in APS is not uncommon. However, acute myocardial infarction (AMI) from in-situ thromb...

Descripción completa

Detalles Bibliográficos
Autores principales: Pervez, Hira, Rufus, Sharan, Gopalakrishnan, Prabhakaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825431/
https://www.ncbi.nlm.nih.gov/pubmed/31723491
http://dx.doi.org/10.7759/cureus.5727
_version_ 1783464898241495040
author Pervez, Hira
Rufus, Sharan
Gopalakrishnan, Prabhakaran
author_facet Pervez, Hira
Rufus, Sharan
Gopalakrishnan, Prabhakaran
author_sort Pervez, Hira
collection PubMed
description Antiphospholipid antibody syndrome (APS) is a systemic autoimmune disorder characterized by arterial and venous thrombosis, often accompanied by elevated titers of anti-phospholipid antibodies. Cardiac involvement in APS is not uncommon. However, acute myocardial infarction (AMI) from in-situ thrombosis is a rare but important manifestation of APS. We present a rare case of AMI in a young female with APS secondary to in-situ coronary thrombosis.
format Online
Article
Text
id pubmed-6825431
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-68254312019-11-13 In-situ Coronary Thrombosis in Antiphospholipid Syndrome: A Case Report Pervez, Hira Rufus, Sharan Gopalakrishnan, Prabhakaran Cureus Rheumatology Antiphospholipid antibody syndrome (APS) is a systemic autoimmune disorder characterized by arterial and venous thrombosis, often accompanied by elevated titers of anti-phospholipid antibodies. Cardiac involvement in APS is not uncommon. However, acute myocardial infarction (AMI) from in-situ thrombosis is a rare but important manifestation of APS. We present a rare case of AMI in a young female with APS secondary to in-situ coronary thrombosis. Cureus 2019-09-23 /pmc/articles/PMC6825431/ /pubmed/31723491 http://dx.doi.org/10.7759/cureus.5727 Text en Copyright © 2019, Pervez et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Rheumatology
Pervez, Hira
Rufus, Sharan
Gopalakrishnan, Prabhakaran
In-situ Coronary Thrombosis in Antiphospholipid Syndrome: A Case Report
title In-situ Coronary Thrombosis in Antiphospholipid Syndrome: A Case Report
title_full In-situ Coronary Thrombosis in Antiphospholipid Syndrome: A Case Report
title_fullStr In-situ Coronary Thrombosis in Antiphospholipid Syndrome: A Case Report
title_full_unstemmed In-situ Coronary Thrombosis in Antiphospholipid Syndrome: A Case Report
title_short In-situ Coronary Thrombosis in Antiphospholipid Syndrome: A Case Report
title_sort in-situ coronary thrombosis in antiphospholipid syndrome: a case report
topic Rheumatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825431/
https://www.ncbi.nlm.nih.gov/pubmed/31723491
http://dx.doi.org/10.7759/cureus.5727
work_keys_str_mv AT pervezhira insitucoronarythrombosisinantiphospholipidsyndromeacasereport
AT rufussharan insitucoronarythrombosisinantiphospholipidsyndromeacasereport
AT gopalakrishnanprabhakaran insitucoronarythrombosisinantiphospholipidsyndromeacasereport

Ejemplares similares